Carlo Croce, an Ohio State University investigator whose work has included elucidating the link between microRNAs and cancer, has been awarded the third annual Albert Szent-Gyorgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research.
The prize includes a $25,000 honorarium.
According to the foundation, Croce’s work has included “groundbreaking discoveries regarding the direct and causative association of chromosomal translocations with the molecular mechanisms of oncogene activation.”
Nastech Pharmaceutical last week announced the scientific advisory board for its RNAi subsidiary, MDRNA.
The SAB includes Roger Kornberg, a Nobel Prize winner and professor at Stanford University; Carl Novina, an RNAi researcher and assistant professor at Harvard Medical School; and James Rothman, a professor at Columbia University and director of the school’s Genome Center.